Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 188
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Numinus Wellness Announces Voting Results From its Annual General and Special...
MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program
Red Light Holland Reports Fiscal Third Quarter Results
Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation...
Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health...
PT297 – Laura Mae Northrup, LMFT – Radical Healership in a...
Psychedelic Bulletin: Following the Money – How Much do Psychedelics Companies...
HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...
Lobe Sciences Ltd. Strengthens Its Balance Sheet
Entheon Biomedical Announces EBIQ-101 First-Patient Dose
Load more